Findings suggest that certain medications for type 2 diabetes reduce risk of dementia
by Keila DePape, McGill University edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Haberdoedas Photography from Pexels A large McGill University study has found that two classes of medications commonly prescribed for type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia. Drawing on clinical data […]
Findings suggest that certain medications for type 2 diabetes reduce risk of dementia Read More »
